Hyloris Pharmaceuticals SA (EBR: HYL)
Belgium
· Delayed Price · Currency is EUR 5.82
-0.08 (-1.36%)
Sep 4, 2024, 2:30 PM CET
Hyloris Pharmaceuticals Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Net Income | -36.18 | -36.18 | -32.77 | -34.31 | -20.01 | -13.48 | Upgrade
|
| Depreciation & Amortization | 0.73 | 0.73 | 0.74 | 0.33 | 0.25 | 0.23 | Upgrade
|
| Other Amortization | - | - | - | - | 0.03 | - | Upgrade
|
| Stock-Based Compensation | 2.56 | 2.56 | 1.69 | 8.56 | 2.7 | 0.29 | Upgrade
|
| Other Operating Activities | 1.78 | 1.78 | 0.71 | 5.81 | 4.41 | 2.57 | Upgrade
|
| Change in Accounts Receivable | 0.49 | 0.49 | 0.14 | -2.36 | -0.22 | -0.02 | Upgrade
|
| Change in Accounts Payable | -1.65 | -1.65 | 2.81 | 2.1 | -0.05 | 0.58 | Upgrade
|
| Operating Cash Flow | -32.27 | -32.27 | -26.69 | -19.87 | -12.9 | -9.85 | Upgrade
|
| Capital Expenditures | -0.42 | -0.42 | -0.39 | -0.09 | -0.17 | -0.12 | Upgrade
|
| Cash Acquisitions | - | - | - | - | - | 0.03 | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | -0.03 | -2.23 | - | - | Upgrade
|
| Investment in Securities | 20 | 20 | -20 | - | - | - | Upgrade
|
| Investing Cash Flow | 19.58 | 19.58 | -20.42 | -2.32 | -0.17 | -0.1 | Upgrade
|
| Long-Term Debt Issued | 1.29 | 1.29 | - | 30 | 3.95 | 11.74 | Upgrade
|
| Long-Term Debt Repaid | -0.48 | -0.48 | -0.56 | -0.14 | -0.13 | -0.1 | Upgrade
|
| Net Debt Issued (Repaid) | 0.81 | 0.81 | -0.56 | 29.86 | 3.82 | 11.65 | Upgrade
|
| Issuance of Common Stock | - | - | - | 80.11 | 0.55 | 4.76 | Upgrade
|
| Other Financing Activities | - | - | - | -4.6 | - | - | Upgrade
|
| Financing Cash Flow | 0.81 | 0.81 | -0.56 | 105.36 | 4.37 | 16.4 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.11 | -0.11 | -0.02 | -0.1 | -0.04 | 0.01 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | -0 | - | - | Upgrade
|
| Net Cash Flow | -11.99 | -11.99 | -47.68 | 83.06 | -8.75 | 6.46 | Upgrade
|
| Free Cash Flow | -32.69 | -32.69 | -27.07 | -19.97 | -13.07 | -9.97 | Upgrade
|
| Free Cash Flow Margin | -6145.11% | -6145.11% | -1260.29% | -1427.09% | -1634.25% | -1799.46% | Upgrade
|
| Free Cash Flow Per Share | -1.08 | -1.08 | -0.90 | -2.10 | -3.63 | -3.30 | Upgrade
|
| Cash Interest Paid | - | - | 0.23 | 0.15 | 0.04 | 0.02 | Upgrade
|
| Cash Income Tax Paid | 0.11 | 0.11 | 0.05 | 0.01 | 0.03 | 0.01 | Upgrade
|
| Levered Free Cash Flow | -21.08 | -21.08 | -15.7 | -14.58 | -9.95 | -7.36 | Upgrade
|
| Unlevered Free Cash Flow | -20.22 | -20.22 | -14.76 | -11.08 | -7.18 | -5.7 | Upgrade
|
| Change in Net Working Capital | 0.92 | 0.92 | -3.25 | -0.18 | 0.28 | -0.64 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.